Occupational PFAS Biomonitoring
Workers in industries with PFAS exposure risk—fluoropolymer manufacturing, AFFF production, firefighting, semiconductor fabrication, and PFAS-contaminated site remediation—may have substantially higher blood PFAS concentrations than the general population. Occupational biomonitoring programs measure blood PFAS levels to assess exposure magnitude and guide health surveillance decisions.
NIOSH Biomonitoring Guidance
NIOSH has conducted Health Hazard Evaluations at multiple facilities with PFAS exposure, developing biomonitoring protocols and reference ranges for occupationally exposed workers. NIOSH guidance recommends baseline PFAS blood testing for newly hired workers in high-exposure occupations, with periodic follow-up monitoring to track exposure trends and facilitate medical surveillance.
Medical Surveillance Components
Comprehensive occupational health surveillance for PFAS-exposed workers should include PFAS serum testing, thyroid function evaluation, lipid panels, liver function tests, and blood pressure monitoring—the organ systems most consistently affected by PFAS exposure in epidemiological studies. Baseline measurements enable longitudinal tracking of biomarker changes over employment.
Worker Rights and Employer Obligations
OSHA’s hazard communication standard requires employers to inform workers about chemical hazards including PFAS in the workplace. NIOSH recommendations for PFAS biomonitoring, while not enforceable standards, represent best practice guidance that health-conscious employers and labor agreements are incorporating into occupational health programs for PFAS-exposed workforces